Streetbeat News

Price Targets

COLB

Stephens & Co. analyst Andrew Terrell maintains an Overweight rating on Columbia Banking System (NASDAQ:COLB) but lowers the price target from $27 to $26.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 12:40 pm

NFLX

Wedbush analyst Michael Pachter maintains an Outperform rating on Netflix (NASDAQ:NFLX) and raises the price target from $475 to $525.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 12:38 pm

TSLA

Wedbush analyst Daniel Ives has reiterated an Outperform rating on Tesla (NASDAQ:TSLA) and raised the price target from $300 to $350.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 12:35 pm

IBM

Wedbush analyst Moshe Katri has reiterated a Neutral rating on IBM (NYSE:IBM) and maintained a price target of $140.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 12:28 pm

ATVI

Wedbush analyst Nick McKay maintains an Outperform rating on Activision Blizzard (NASDAQ:ATVI) and raises the price target from $95 to $95.99.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 12:25 pm

IMAX

Wedbush analyst Alicia Reese has reiterated her 'Outperform' rating on Imax (NYSE:IMAX), maintaining a price target of $26.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 12:24 pm

NUVL

Wedbush analyst David Nierengarten has reiterated an Outperform rating on Nuvalent (NASDAQ:NUVL) and maintained a $53 price target.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 12:23 pm

APLS

Wedbush analyst Laura Chico has maintained a Neutral rating on Apellis Pharmaceuticals (NASDAQ:APLS) and lowered the price target from $86 to $40.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 12:22 pm

ZION

Goldman Sachs analyst Ryan Nash maintains a Neutral rating on Zions Bancorp (NASDAQ:ZION) and raises the price target from $30 to $37.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 12:21 pm

ZION

Wedbush analyst Peter Winter has maintained a Neutral rating on Zions Bancorp (NASDAQ:ZION) and raised the price target from $30 to $38.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 12:20 pm